The basic idea of PD-1/PD-L1 blockade is to block the interaction of PD-1 on T cells and PD-L1 on tumor cells, which offers tumor cells additional resistance to T-cell-mediated apoptosis, thus preventing cancer cells from defending themselves against antitumor immune responses (Azuma et al., 2008). Here, CD274 is linked to neoplasm.